Updated 12:02 GMT, 29 Oct 2026 SPX 7,743.98 +0.28% NDX 29,813.16 +0.55% VIX 17.11 +1.18% GOLD 4,038.70 -0.32% CL 101.96 -0.80% BTC 80,016.71 -1.54%
NAS100 29,813 +0.55% S&P 7,744 +0.28% GOLD $4,039 −0.32% BTC $80,017 −1.54% VIX 17.11 +1.18% latest tape · as of 12:02 UTC
The Screen · Healthcare

PetMed Express, Inc.

PETS · Nasdaq · USD · Market cap $46M

FAIL · Does not pass the screen
1.16 USD

Price as of 26 Oct 2026Daily close, not a live quote

Screened 2026-10-26 · the tape above runs as of 12:02 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price1.16 USD at the 26 Oct 2026 close
  • Ethical screenDoes not pass
  • Last reviewed26 Oct 2026 (3 days ago)

A summary of the dated readings below, not a live quote and not advice.

PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y

What this means: price 1.16 against the desk's fair-value range, over the last year.

Current read
Markdown ?
Screened · screened 2026-10-26
  • Trend Markdown
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical does not pass the values gate
Price1.16 USD
Our investment reviews on this name
2026-09-09Read Markdown1.68-31.0% to today ✓Distribution gives way to Markdown first Markdown read since July
2026-08-08Read Distribution1.68-31.0% to today ✓Markdown gives way to Distribution
2026-07-02Read Markdown1.68-31.0% to today ✓First review on file: Markdown

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markdown label.

PetMed Express, Inc. holds its Markdown at $1.16. Consolidating, no directional conviction, held for 70 days.

As held on the ledger · 2026-10-26
PhaseMarkdown · caution
Quantitative stateConsolidating, no directional conviction, held for 70 days
Price at the screen$1.16
Valuation0.00 trailing · -71.92 forward price to earnings
Values screenFAIL
The Workings

Five Screens, Shown in Full

Does not pass. Cash ratio

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 1.41% Below 33% Interest-bearing debt is just 1.4% of its assets, well under the one-third ceiling: it does not run on borrowed money. Pass
Interest-bearing cash 58.29% Below 33% Interest-bearing cash and securities are 58.3% of assets, above the one-third limit. Fail
Receivables 0.00% Below 49% Money owed to the company is 0.0% of assets, under the 49% limit. Pass
Revenue purity 0.29% Below 5% Only 0.3% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

PetMed Express,'s business is fine, but its cash and interest-bearing securities are about 58% of its assets, well over the ~33% line, so it does not pass on the financial screens.

Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when PETS's ethical verdict changes

Today PETS does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

The Business, in Plain Words
The fundamentals · plain-English read
Forward P/E-71.9x
Trailing P/E0.0x
EPS, trailing-3.11
EPS, forward-0.03
Revenue growth-21.7%revenue is shrinking
Profit margin-34.7%currently unprofitable
Return on equity-100.6%not currently earning a positive return on equity
Debt to equity0.02minimal debt: a conservative balance sheet
Market cap$46M

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

PETS trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-10-21 Markdown $1.20 -25.0% Entry 7

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 25.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 59%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (1 analysts) rates it none, with a mean price target of $2.

2026-10-02 Markdown $1.60 -4.8% Entry 6

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 4.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 59%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (1 analysts) rates it none, with a mean price target of $2.

2026-09-09 Markdown · changed $1.68 +0.0% Entry 5

The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 59%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (1 analysts) rates it none, with a mean price target of $2.

2026-08-08 Distribution · changed $1.68 +0.0% Entry 4

The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 59%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (1 analysts) rates it none, with a mean price target of $2.

2026-07-18 Markdown $1.68 +0.0% Entry 3

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 59%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (1 analysts) rates it none, with a mean price target of $2.

2026-07-03 Markdown $1.68 +0.0% Entry 2

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.

2026-07-02 Markdown $1.68 Entry 1

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · PETS
DateInsiderTitleTypeSharesValue
2025-10-30 FULGONI GIAN M Director 33,846 ·
2025-10-30 MENNEN JUSTIN L. Director 33,846 ·
2025-10-30 LACAMP JAMES Director 34,866 ·
2025-10-30 SOLIVAN LEAH A. Director 33,846 ·
2025-10-30 BATUSHANSKY PETER Director 33,846 ·
2025-10-30 KRULIK DOUGLAS Chief Financial Officer 20,000 ·
2025-09-09 KRULIK DOUGLAS Officer 10,000 ·
2025-08-13 SILVERCAPE INVESTMENTS LTD. Beneficial Owner of more than 10% of a Class of Security 101,000 $320,170
2025-08-01 SILVERCAPE INVESTMENTS LTD. Beneficial Owner of more than 10% of a Class of Security 118,200 $379,422
2025-07-21 NINA CAPITAL HOLDINGS INC Beneficial Owner of more than 10% of a Class of Security 25,000 $87,425

Public filings, recorded as found. The full tape lives at Insider Intelligence.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $2.26 -23.9% · $761 -23.9%
2 months $2.30 -25.2% · $748 -25.2%
3 months $2.43 -29.2% · $708 -29.2%
6 months $2.98 -42.3% · $577 -42.3%
1 year $4.19 -59.0% · $411 -59.0%
2 years $4.20 -59.1% · $410 -59.1%
3 years $14.61 -88.2% $0.30 $138 -86.2%
5 years $28.70 -94.0% $2.70 $154 -84.6%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever PETS does next, these words stay.

PetMed Express, Inc. · PETS · Markdown · $1.16
Recorded 2026-10-26 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.